Using mobile health to help underserved urban residents manage hypertension
Mobile Health for Enhanced Hypertension Self-Management in Underserved Urban Residents
This study is looking to help people with high blood pressure who live in urban areas and face economic challenges by using mobile health tools to support healthier lifestyles and better self-care, while also considering how their neighborhoods impact their health.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10897035 on NIH RePORTER |
What this research studies
This research focuses on improving hypertension management among socioeconomically disadvantaged individuals in urban areas through mobile health (mHealth) strategies. It aims to understand how social factors in neighborhoods affect hypertension control and to develop a tailored mHealth intervention that encourages lifestyle changes and self-management. The study will involve engaging community residents to ensure the intervention meets their needs and will assess its feasibility through a pilot study.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults living in urban areas who are socioeconomically disadvantaged and at high risk for hypertension-related health issues.
Not a fit: Patients who do not live in urban settings or who are not affected by hypertension may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could empower patients in underserved communities to better manage their hypertension and improve their overall cardiovascular health.
How similar studies have performed: Previous research has shown that mobile health interventions can be effective in promoting health behavior changes, particularly in underserved populations, indicating a promising approach.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Johnson, Amber Elaine — University of Chicago
- Study coordinator: Johnson, Amber Elaine
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.